Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

372.21 +3.07 (+0.83%)

Delayed Quote Updated: 12:06 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday ↗

February 16, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

Via Benzinga

Topics Stocks

Bio-Rad Laboratories: Q4 Earnings Insights ↗

February 15, 2024

Via Benzinga

Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results

February 15, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Preview: Bio-Rad Laboratories's Earnings ↗

February 14, 2024

Via Benzinga

Earnings Outlook For Bio-Rad Laboratories ↗

October 25, 2023

Via Benzinga

Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading

September 13, 2023

Via Investor Brand Network

The Latest Analyst Ratings for Bio-Rad Laboratories ↗

August 04, 2023

Via Benzinga

Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024

January 24, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps? ↗

January 23, 2024

S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upside potential for 2024 rally.

Via Benzinga

Topics Artificial Intelligence Economy Stocks

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference

January 02, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Latest Analyst Ratings for Bio-Rad Laboratories ↗

June 16, 2023

Via Benzinga

Death Cross Looms Over Bio-Rad Laboratories Investors ↗

May 24, 2023

Via Benzinga

S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets ↗

December 07, 2023

Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%).

Via Benzinga

Topics Stocks

Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations ↗

November 24, 2023

Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.

Via Benzinga

Topics Stocks

Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today? ↗

October 27, 2023

Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 26, 2023

Via Benzinga

Bio-Rad Reports Third-Quarter 2023 Financial Results

October 26, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 17, 2023

Via Benzinga

Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023

October 05, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

3 Beaten-Down Biotech Stocks Bound for a Bounce Back ↗

September 02, 2023

Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.

Via InvestorPlace

Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference

August 28, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Reports Second-Quarter 2023 Financial Results

August 03, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement

July 26, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Why Are velo Biosciences Stock Is Trading Higher Today? ↗

July 21, 2023

Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO).

Via Benzinga

Bio-Rad Announces New Share Repurchase Program

July 20, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023

July 10, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Publishes Corporate Sustainability Report for 2022

July 10, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023 ↗

June 16, 2023

Via Benzinga

Bio-Rad to Present Company Overview at Jefferies Healthcare Conference

June 01, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.